Severe acute respiratory syndrome (SARS) is a debilitating and dangerous human syndrome caused by coronavirus infection. Coronaviruses enters the human body by binding to angiotensin-converting enzyme 2 (ACE2), and thus animal models that express ACE2 are useful for the study of coronavirus associated respiratory diseases. Traditional knock-in animal models are labor-intensive and require at least six months to build as well as extensive resource allocations to maintain. PackGene has generated AAV-based animal models that overexpress the hACE2 protein in specific organs, making them suitable for coronavirus studies including COVID-19-related studies.
PackGene’s model takes advantage of rAAV serotype tropisms to selectively infect specific tissues in mice for generating AAV-hACE2 animal models. AAV infected tissues show continuous and stable expression of the hACE2 protein producing in a simple and timesaving method for new coronavirus-related drug development and research.
Comparison between AAV-hACE2 animal modeling and traditional animal modeling:
|AAV-hACE2 animal modeling
||Traditional animal modeling
|Production Cycle||Short cycle within 14 days||Over 6 months|
|Histotropism||Specific distribution||Wide distribution|
Injection Method: Intranasal Administration
Recommended Dose: 2×10^11GC/ml, 40μl
Animal Model: 6-8-week-old female BALB/c mice
Journal: Antiviral Research, 2022 (IF=10.103)
Paper Title: Rational design of AAVrh10-vectored ACE2 functional domain to broadly block the cell entry of SARS-CoV-2 variants
Related Services / Products
Off the Shelf AAV Products
We offer a wide catalogue of pre-made AAVs for a multitude of research needs.
AAV Packaging Services
Ranging from pilot to industrial-scale AAV packaging for both in vitro and in vivo studies.
AAV Analytical Services
We are one of the few vendors that can do ALL in-house.